Pluristem Therapeutic (PSTI)

Add to Watchlists
Create an Alert
3.54 +0.06  +1.72% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD

Pluristem Therapeutic Gross Profit Margin (Quarterly):

96.84% for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Pluristem Therapeutic Gross Profit Margin (Quarterly) Chart

Export Data
Save Image

Pluristem Therapeutic Historical Gross Profit Margin (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 96.84%
Sept. 30, 2013 96.84%
June 30, 2013 97.89%
March 31, 2013 96.91%
Dec. 31, 2012 96.92%
   
Sept. 30, 2012 96.92%
June 30, 2012 97.03%
March 31, 2012 97.39%
Dec. 31, 2011 96.97%
Sept. 30, 2011 96.75%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Gross Profit Margin

A gross profit margin is the difference between sales and the cost of goods sold divided by revenue. This represents the percentage of each dollar of a company's revenue available after accounting for cost of goods sold.

If a company produces phones and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32M - $24M) / $32M = 25 percent.

Cutting costs result in higher gross profit margins. If a company sells phones for 500 dollars and the cost of the producing the phone is $250, the current gross profit margin is 50 percent ((500-250)/500). If the company is able to reduce production costs from $250 to $200, the gross profit margin is 60 percent ((500-200)/500).

Note : Profit margins are very dependent on sector. Companies that sell bland potato chips may not have very high margins, but will sell a sizable quantity of potato chips. A company that sells consulting services will likely have higher profit margins, but sell lower quantities.
Learn More

Get data for
Advertisement

PSTI Gross Profit Margin (Quarterly) Benchmarks

Companies
United Therapeutics 86.58%
Actelion 88.08%
Biogen Idec 86.85%

PSTI Gross Profit Margin (Quarterly) Range, Past 5 Years

Minimum 96.75% Sep 2011
Maximum 97.89% Jun 2013
Average 97.05%
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.